Securities Class Action
Everest Group, Ltd. NYSE: EG
Shareholders who purchased Everest Group, Ltd. (EG) stock may have claims in this securities fraud class action lawsuit alleging Everest understated its casualty insurance reserves and overstated its earnings, which triggered sharp stock price drops.
← Current Cases · SPAC-Warrant Cases · Under Investigation · Case Archive
- Class period
- February 8, 2024 to October 27, 2025
- Lead plaintiff deadline
- December 28, 2026
- Court
- U.S. District Court, S.D.N.Y., No. 1:26-cv-09448
- Year
- 2026
A securities fraud class action lawsuit has been filed against Everest Group, Ltd. (“Everest” or the “Company”) (NYSE: EG) on behalf of shareholders who purchased or otherwise acquired the Company's securities between February 8, 2024 and October 27, 2025, inclusive (the “Class Period”). Everest is a global provider of reinsurance and insurance products.
The complaint alleges that, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Everest remained materially exposed to and concentrated in casualty risks subject to escalating claim costs, including business defendants claimed Everest had reduced or exited; (2) Everest had inadequately priced portions of that business; (3) Everest's reserves were insufficient, causing it to understate its liabilities and expenses and materially overstate its earnings; and (4) addressing these problems would require substantial reserve charges, protection against further adverse development, and reductions in Everest's casualty business, thereby sacrificing recurring premium revenue.
The truth emerged in a series of disclosures. On October 30, 2024, Everest reported that U.S. casualty loss activity had “spiked,” and its stock fell approximately 6.4%, to $355.61 per share. On January 27, 2025, Everest announced roughly $1.7 billion of reserve strengthening, and its stock fell approximately 5.8% over the next two trading days, to $351.51 per share. On October 27, 2025, Everest disclosed $478 million of unfavorable prior-year reserve development, and its stock fell approximately 11.4% the next day, from $343.98 to $304.91 per share.
Think you may be a shareholder affected by this stock drop?
Free Case Evaluation